<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Internuclear ophthalmoparesis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Internuclear ophthalmoparesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Internuclear ophthalmoparesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Teresa C Frohman, MSPA, PA-C, FANA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Axel Petzold, MD, PhD, FRCP, FRCOphth</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elliot M Frohman, MD, PhD, FANA, FAAN</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul W Brazis, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 07, 2020.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Internuclear ophthalmoparesis (INO), also commonly referred to as internuclear ophthalmoplegia, is a specific gaze abnormality characterized by impaired horizontal eye movements with weak and slow adduction of the affected eye, and abduction nystagmus of the contralateral eye. It is one of the most localizing brainstem syndromes, resulting from a lesion in the medial longitudinal fasciculus (MLF) in the dorsomedial brainstem tegmentum of either the pons or the midbrain [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H2"><span class="h1">OCULOMOTOR CIRCUITRY</span><span class="headingEndMark"> — </span>Foveation or visual targeting with binocular fusion and stereoscopy (depth perception) requires highly synchronous eye movements that place objects of visual interest on the corresponding points of both retinas. This process is dependent upon the precise coordination between cranial nerves II, III, IV, and VI, and their interneuronal pathways that project through the medial longitudinal fasciculus (MLF)  (<a class="graphic graphic_figure graphicRef62010" href="/z/d/graphic/62010.html" rel="external">figure 1</a>).</p><p>The paramedian pontine reticular formation (PPRF) is often referred to as the conjugate gaze center for horizontal eye movements. During horizontal eye movement, the PPRF burst cells innervate the abducens nucleus, which contains two distinctive sets of neurons: </p><p class="bulletIndent1"><span class="glyph">●</span>Axons of the abducens motor neurons directly innervate the ipsilateral lateral rectus muscle. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Axons of the abducens interneurons cross the midline to become the MLF and subsequently innervate the medial rectus subnucleus of the oculomotor complex (cranial nerve nucleus III). Motor neurons from this subnucleus innervate the medial rectus muscle (ipsilateral to the medial rectus subnucleus and contralateral to the abducens nucleus). </p><p></p><p>The MLF exists as a pair of white matter fiber tracts that lie near the midline just under (or ventral to) the fourth ventricle and cerebral aqueduct, and extend through the dorsomedial pontine and midbrain tegmentum. Because of their close physical proximity near the midline, bilateral injury is common. While the MLF is primarily involved in coordinating synchronous horizontal eye movements, it also contains pathways involved in the regulation of vertical pursuit, vertical vestibular signals, and vertical alignment of the two eyes (a process mediated by the otolith organs of the inner ear and their central projections) [<a href="#rid2">2-8</a>]. </p><p>An INO results from injury to the MLF within the dorsomedial pontine or midbrain tegmentum. The side of the INO is named by the side of the adduction deficit, which is ipsilateral to the MLF lesion [<a href="#rid9">9,10</a>].</p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H25489472"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>Patients with INO may complain of horizontal diplopia when there is a significant adduction weakness or limitation on lateral gaze [<a href="#rid3">3</a>]. Diplopia is not usually present in primary gaze. However, some patients complain of vertical diplopia in the primary position due to skew deviation of eyes.</p><p>The dysconjugate movement of the two eyes during horizontal gaze results in an interruption in binocular fusion that can lead to visual confusion, oscillopsia, diplopia, reading fatigue, and loss of stereopsis (depth perception) [<a href="#rid11">11</a>]. Some patients also complain of vertigo [<a href="#rid3">3</a>]. Visual symptoms may be particularly problematic with head turning, especially while walking or driving, and can increase the risk of falls and motor vehicle accidents [<a href="#rid11">11</a>]. </p><p class="headingAnchor" id="H1358858267"><span class="h2">Signs</span><span class="headingEndMark"> — </span>Important findings on examination include impaired adduction on lateral gaze, with nystagmus in the contralateral, abducting eye. Other signs may also be observed. Many patients, particularly those with demyelinating disease, will have bilateral involvement.</p><p class="headingAnchor" id="H4"><span class="h3">Adduction weakness</span><span class="headingEndMark"> — </span>Depending on the severity of the lesion, adduction of the involved eye may be impaired or absent. If the defect is severe (as in severe demyelination and/or with axonal transection), then the observer may identify partial or even complete absence of adduction.</p><p>In milder forms, the deficit may be limited to a decrease in adduction velocity without ocular limitation  (<a class="graphic graphic_figure graphicRef53437" href="/z/d/graphic/53437.html" rel="external">figure 2</a>). Evidence of milder forms of INO may be best elicited by asking the patient to perform fast horizontal eye movements (saccades) away from a fixed central point, or by observing the speed of the adducting eye during its return to a central point of fixation from an eccentric point of gaze holding. Perhaps the most sensitive method to demonstrate a subtle adduction lag is to observe the fast phase (saccade) of optokinetic (OKN) nystagmus, while using an alternately striped fabric strip.</p><p>Interruption of the ascending axons in the medial longitudinal fasciculus (MLF) that arise from the internuclear neurons in the contralateral abducens nucleus likely explains the observed adduction deficit.</p><p class="headingAnchor" id="H5"><span class="h3">Normal convergence</span><span class="headingEndMark"> — </span>Most lesions of the MLF are located in the pons or caudal mesencephalon, sparing the vergence pathways, including the fibers deriving from the medial rectus subnucleus of cranial nerve III [<a href="#rid12">12,13</a>]. As a result, convergence is intact in the majority of patients despite adduction weakness on lateral gaze. Intact convergence can help distinguish an INO from a partial third nerve palsy; however, impaired convergence does not rule out an INO. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h3">Abduction nystagmus</span><span class="headingEndMark"> — </span>The contralateral abducting eye will usually exhibit a horizontal nystagmus, which is less prominent in the adducting eye, although this does not always occur.</p><p>The underlying mechanisms causing abducting nystagmus are unknown. There is evidence that more than one mechanism may play a role in different patients and even in the same patient [<a href="#rid13">13</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>One theory with empiric support is that abduction nystagmus results from an adaptive response to overcome the weakness of the contralateral medial rectus [<a href="#rid13">13,14</a>]. This is explained by Hering's law of equal innervation, which states that attempts to increase innervation to the weak (medial rectus) muscle in one eye are accompanied by a commensurate increase in innervation to the yoke (lateral rectus) muscle in the other eye. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alternatively, gaze-evoked nystagmus may occur in patients with INO because of involvement of adjacent structures, such as the vestibular nuclei [<a href="#rid13">13</a>]. The nystagmus is dissociated because adductor weakness limits its manifestation in the affected eye. Subclinical nystagmus in the adducting eye has been demonstrated with electro-ocular techniques [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h3">Abduction slowing</span><span class="headingEndMark"> — </span>In some patients, INO can produce slowing of abduction as well as adduction in the affected eye [<a href="#rid13">13,16</a>]. This small degree of abduction slowing is expected in the context of adduction weakness, because of the loss of the contribution of the off-pulse of innervation (defective relaxation) when the medial rectus acts as an antagonist [<a href="#rid17">17</a>]. This can be distinguished from a sixth nerve palsy by noting that the eyes are aligned in primary position, there is full range of abduction on pursuit, and there are preserved abduction saccades with caloric testing [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H8"><span class="h3">Abnormal vertical eye movements</span><span class="headingEndMark"> — </span>Patients with INO often exhibit abnormalities with vertical eye movements, including [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Vertical gaze-evoked nystagmus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skew deviation with the elevation of the weak adducting eye. </p><p></p><p class="bulletIndent1">Pontine lesions produce hyperdeviation (elevation) of the ipsilateral eye, often in conjunction with a homolateral INO. For example, a right dorsomedial pontine tegmentum lesion can produce a right eye hyperdeviation due to skew deviation, as well as a right INO, with slow adduction of the right eye during attempted leftward saccades. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Contraversive ocular tilt reaction – In the ocular tilt reaction, the head tilts away from the side of the higher eye, the upper pole of the higher eye is intorted toward the nose, and the upper pole of the lower eye is extorted away from the nose. By contrast, in a fourth nerve palsy with superior oblique muscle weakness, there is extorsion of the higher eye. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diminished vertical gaze holding.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal OKN and pursuit responses.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Suppressed vestibular ocular reflex (VOR).</p><p></p><p>These supplementary signs are inconsistently present, more often with bilateral than unilateral INO, and are not required for the diagnosis of INO [<a href="#rid18">18</a>]. Rather, they might be more accurately designated as so-called INO+ syndromes. </p><p class="headingAnchor" id="H9"><span class="h2">Associated syndromes</span></p><p class="headingAnchor" id="H10"><span class="h3">One-and-a-half syndrome</span><span class="headingEndMark"> — </span>This syndrome consists of a gaze palsy in one direction with an INO on horizontal gaze in the opposite direction. With attempted horizontal gaze, only abduction of the contralateral eye remains. Convergence is spared. In primary (neutral gaze), the contralateral eye is slightly abducted (so-called paralytic pontine exotropia). This syndrome is produced by damage to the paramedian pontine reticular formation (PPRF) and/or abducens nucleus and MLF on the same side. If the abducens nucleus is spared, the gaze palsy is apparent on volitional horizontal gaze, but is normal with oculocephalic maneuvers, as volitional eye movement requires activation of the PPRF, but the VOR does not.</p><p>As an example, a left paramedian pontine tegmentum lesion affecting the PPRF, abducens nucleus, and MLF produces a left gaze paresis as well as a left INO on attempted right gaze. During primary (forward) gaze, the right eye is slightly abducted. </p><p class="headingAnchor" id="H11"><span class="h3">Wall-eyed bilateral INO (WEBINO)</span><span class="headingEndMark"> — </span>If the lesion affects the MLF within the upper midbrain, vergence pathways and the oculomotor apparatus can be disrupted, resulting in a variety of eye movement abnormalities that include impaired convergence [<a href="#rid13">13,14,16,19</a>]. These lesions are typically bilateral and produce divergence of the eyes (wall-eyed), along with bilateral INO, the WEBINO syndrome.</p><p class="headingAnchor" id="H1408029971"><span class="h3">Eight-and-a-half syndrome</span><span class="headingEndMark"> — </span>This syndrome consists of the one-and-a-half syndrome plus lower motor neuron pattern facial weakness on the side ipsilateral to the INO [<a href="#rid20">20-26</a>]. This occurs when there is involvement of the fascicle of the ipsilateral facial nerve (CN VII) at the level of the facial colliculus [<a href="#rid27">27,28</a>].</p><p class="headingAnchor" id="H12"><span class="h1">CAUSES</span><span class="headingEndMark"> — </span>There are many potential causes of INO  (<a class="graphic graphic_table graphicRef78378" href="/z/d/graphic/78378.html" rel="external">table 1</a>). Most cases (approximately 70 percent) of INO are due to multiple sclerosis (MS) or cerebrovascular disease [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Multiple sclerosis</span><span class="headingEndMark"> — </span>MS underlies approximately one-third of cases of INO and is the most common cause in a young person (&lt;45 years). The deficit is bilateral in most (73 percent) [<a href="#rid29">29</a>].</p><p>INO is also the most common eye movement abnormality in MS. The reported prevalence of INO among patients with MS varies between 17 and 41 percent of patients, depending in part on whether the INO is a clinical manifestation or an incidental finding on examination, as well as on the techniques used to elicit this finding [<a href="#rid30">30-33</a>] (see <a class="local">'Diagnosis'</a> below). The periventricular location of the medial longitudinal fasciculus (MLF) is thought to make this area particularly susceptible to autoimmune inflammatory demyelination [<a href="#rid1">1</a>].</p><p>Clinical signs in MS may be exacerbated by small increases in body temperature (as with exposure to high ambient temperature, fever, during exercise; also known as Uhthoff phenomenon) (see  <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">"Manifestations of multiple sclerosis in adults", section on 'Heat sensitivity'</a>). This has been modeled in our laboratory in MS patients with INO, using infrared eye movement recording techniques [<a href="#rid34">34-36</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Cerebrovascular disease</span><span class="headingEndMark"> — </span>The most common cause of INO in an older patient is ischemic infarction. These patients are typically older than patients with MS, with an average age of 62 to 66 years [<a href="#rid3">3,37</a>]. In addition to advanced age, vascular risk factors (hypertension, diabetes mellitus, smoking) are prevalent in these patients. In contrast to MS, INO in this setting is usually (in 87 to 93 percent of cases) unilateral [<a href="#rid3">3,29</a>].</p><p>The underlying stroke subtype is usually small artery occlusion or lacunar disease involving the penetrating arteries originating from the basilar artery. Large branch artery occlusions in the basilar, superior cerebellar, and posterior cerebral arteries have also been associated with infarctions producing INO [<a href="#rid3">3</a>]. In large case series, individual cases of INO are reported with many other stroke subtypes, including hemorrhage (hypertensive, vascular malformation), vertebral artery dissection, temporal arteritis, and other vasculitides [<a href="#rid29">29</a>].</p><p>More than half of patients with an INO due to brainstem infarction have other neurologic symptoms and signs in addition to INO, including sensory deficits, dysarthria, gait ataxia, and lower motor neuron facial palsy, but isolated INO can occur as well [<a href="#rid3">3</a>]. </p><p class="headingAnchor" id="H15"><span class="h2">Others</span><span class="headingEndMark"> — </span>A large number of causes make up the one-quarter to one-third of INO cases that are not due to MS or cerebrovascular disease  (<a class="graphic graphic_table graphicRef78378" href="/z/d/graphic/78378.html" rel="external">table 1</a>) [<a href="#rid6">6,29</a>]. The most common of these are infection, trauma, and tumor. In some remarkable cases, mild head injury can produce an isolated unilateral or bilateral INO [<a href="#rid38">38-40</a>].</p><p class="headingAnchor" id="H16"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>A partial third nerve palsy with prominent medial rectus weakness may be confused with an INO. Distinguishing features include other third nerve deficits (weakness of elevation, ptosis, pupil dilation), impaired convergence, and absence of the contralateral abduction nystagmus, all of which point to a third nerve palsy rather than an INO. (See  <a class="medical medical_review" href="/z/d/html/5246.html" rel="external">"Third cranial nerve (oculomotor nerve) palsy in adults"</a>.)</p><p>There are reports of eye movement abnormalities in progressive supranuclear palsy (PSP) that suggest bilateral INO [<a href="#rid41">41</a>]. Parkinsonism and other features of PSP are present in these individuals, and the eye movement abnormality can be overcome with oculocephalic maneuvers in PSP (because the lesion is supranuclear) but not in an INO. (See  <a class="medical medical_review" href="/z/d/html/6231.html" rel="external">"Bradykinetic movement disorders in children"</a>.)</p><p>A pseudo-internuclear ophthalmoparesis is a well-described phenomenon in patients with myasthenia gravis and Guillain-Barré syndrome [<a href="#rid18">18,29,42-44</a>]. In practice, this is most often observed in the setting of an established diagnosis of these disorders, but can be observed at first presentation. The presence of ptosis and lid fatigue will alert the clinician to myasthenia, while areflexia, often with ataxia or limb weakness, will suggest the Miller-Fisher variant of Guillain-Barré syndrome. (See  <a class="medical medical_review" href="/z/d/html/5137.html" rel="external">"Guillain-Barré syndrome in adults: Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5170.html" rel="external">"Clinical manifestations of myasthenia gravis"</a>.)</p><p>Findings suggestive of a bilateral INO have also been reported in the setting of drug overdose; however, these individuals universally have an impaired level of consciousness [<a href="#rid29">29,45</a>].</p><p class="headingAnchor" id="H17"><span class="h1">EVALUATION AND DIAGNOSIS</span></p><p class="headingAnchor" id="H19"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of an INO is made by the combined presence of impaired horizontal eye movements with weak, slow adduction of the affected eye, and abduction nystagmus of the contralateral eye. </p><p>Subtle forms of INO can be overlooked on examination and may only be evident on formal oculographic recording, which measures the velocity and acceleration of abduction and adduction [<a href="#rid15">15,18,30,46,47</a>]. Compared with these quantitative oculographic techniques, the accuracy of clinical examination by clinicians to detect an INO was imperfect (with both false positives and negatives), even by neuro-ophthalmologists [<a href="#rid33">33,48</a>].</p><p>The bedside neurologic examination for INO can be improved by the use of an optokinetic (OKN) tape. This is a highly sensitive technique for observing subtle adduction slowing in INO, and allows for more effective observation of saccadic dysconjugacy during the fast phase of nystagmus [<a href="#rid49">49</a>]. (See <a class="local">'Adduction weakness'</a> above.)</p><p>This specialized testing may have clinical utility in the setting of possible multiple sclerosis (MS), in which the identification of a second site of neurologic abnormality can influence diagnosis and treatment decisions.</p><p class="headingAnchor" id="H25489693"><span class="h2">Magnetic resonance imaging</span><span class="headingEndMark"> — </span>Patients who present with an INO require brain magnetic resonance imaging (MRI) to include axial T2 or proton density-weighted images with 3 mm slice thickness [<a href="#rid50">50</a>]. A normal brain MRI should suggest an alternative cause of the extraocular movement disorder or pseudo-INO. Contrast enhancement and other specialized MRI sequences may enhance sensitivity, depending on the most likely etiology. We order these selectively.</p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 58 patients with MS and INO, all had an abnormality within the region of the medial longitudinal fasciculus (MLF) on proton density imaging; other MRI sequences (T2-weighted, fluid-attenuated inversion recovery [FLAIR]) were less sensitive [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another case series described MRI findings in 30 patients with brainstem infarction [<a href="#rid3">3</a>]. In two cases, diffusion-weighted MRI identified an acute infarction that was not detected on T2-weighted MRI.</p><p></p><p class="headingAnchor" id="H20"><span class="h1">PROGNOSIS AND TREATMENT</span><span class="headingEndMark"> — </span>Recovery from INO is variable. Deficits often resolve over a few to several months; however, symptoms and signs persist in many patients, regardless of the underlying etiology [<a href="#rid3">3,6,33,37</a>]. In one series, patients with a cerebrovascular origin were less likely to recover than those with other causes; 63 percent had persistent symptoms after three years [<a href="#rid6">6</a>]. However, others have observed a better prognosis with INO due to brainstem infarction, with 79 to 87 percent recovery in two to three months [<a href="#rid3">3,37</a>]. Restricted neurologic deficits and absence of a lesion on T2-weighted magnetic resonance imaging (MRI) appear to be associated with a better prognosis of recovery from INO in stroke patients [<a href="#rid3">3,6,37</a>]. </p><p>Patients with severe diplopia may be treated with patching of one eye. In our experience, some patients with milder deficits can be trained to supplement horizontal eye movements by quick head movements. Prisms are not typically helpful in this setting.</p><p>Other treatment options are investigational. <a class="drug drug_general" data-topicid="9095" href="/z/d/drug information/9095.html" rel="external">Dalfampridine</a> (4-aminopyridine; fampridine), a potassium channel blocker, may improve axonal function in patients with demyelinating disease. One report documents objective improvement of ocular adduction in three patients with multiple sclerosis (MS) and chronic bilateral asymmetric INO [<a href="#rid51">51</a>]. Only one patient had subjective improvement in vision. In a small randomized trial including 23 patients with MS-related INO, fampridine produced objective improvement of saccadic eye movements; effects on patient symptoms were not reported [<a href="#rid52">52</a>]. While dalfampridine is approved for treatment of gait impairment in MS, the appropriate clinical use has not been clearly defined in that setting. (See  <a class="medical medical_review" href="/z/d/html/1690.html" rel="external">"Symptom management of multiple sclerosis in adults", section on 'Dalfampridine'</a>.)</p><p>In one center, injection of botulinum toxin into one or more extraocular muscles was associated with improved diplopia in 14 of 16 patients with an INO in the setting of brainstem hemorrhage, MS, or other cause [<a href="#rid52">52,53</a>]. However, this treatment approach is not yet widely used. </p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Internuclear ophthalmoparesis (INO) is a specific gaze abnormality, characterized by impaired horizontal eye movement with slow, weak adduction of the affected eye and abduction nystagmus of the contralateral eye. In typical cases, convergence is spared. Abnormalities of vertical gaze are common but are not required features of an INO diagnosis. (See <a class="local">'Clinical features'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An INO is one of the most localizing brainstem syndromes, resulting from a lesion in the medial longitudinal fasciculus (MLF) in the dorsomedial brainstem tegmentum of either the pons or the midbrain. (See <a class="local">'Oculomotor circuitry'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>More than two-thirds of cases result from multiple sclerosis (MS) or cerebrovascular disease. Patients with MS are typically young (less than 45 years), and the INO is usually bilateral. Patients with cerebrovascular disease are rarely less than 45 years old, have prevalent vascular risk factors, and are more likely to have a unilateral INO. Infections, tumors, and trauma cause most other cases. (See <a class="local">'Causes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An INO can be confused with a partial third nerve palsy, other supranuclear gaze disturbances, or peripheral neuromuscular disease, especially ocular myasthenia gravis. However, a careful neurologic examination can usually distinguish between these entities. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All patients who present with INO require brain magnetic resonance imaging (MRI). Contrast enhancement and other specialized MRI sequences can increase the sensitivity of MRI for specific diagnoses. (See <a class="local">'Magnetic resonance imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most patients will recover within a few to several months. However, some will have deficits that persist. (See <a class="local">'Prognosis and treatment'</a> above.) </p><p></p><p class="headingAnchor" id="H330114912"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The authors would like to acknowledge Ethan Meltzer, MD, who contributed to a revision of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Frohman EM, Zhang H, Kramer PD, et al. MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis. Neurology 2001; 57:762.</a></li><li class="breakAll">Wray SH. Horizontal gaze and syndromes of the pons. In: Eye Movement Disorders in Clinical Practice, Oxford University Press, New York 2014. p.207.</li><li><a class="nounderline abstract_t">Kim JS. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology 2004; 62:1491.</a></li><li><a class="nounderline abstract_t">Evinger LC, Fuchs AF, Baker R. Bilateral lesions of the medial longitudinal fasciculus in monkeys: effects on the horizontal and vertical components of voluntary and vestibular induced eye movements. Exp Brain Res 1977; 28:1.</a></li><li><a class="nounderline abstract_t">Ranalli PJ, Sharpe JA. Vertical vestibulo-ocular reflex, smooth pursuit and eye-head tracking dysfunction in internuclear ophthalmoplegia. Brain 1988; 111 ( Pt 6):1299.</a></li><li><a class="nounderline abstract_t">Bolaños I, Lozano D, Cantú C. Internuclear ophthalmoplegia: causes and long-term follow-up in 65 patients. Acta Neurol Scand 2004; 110:161.</a></li><li><a class="nounderline abstract_t">Cremer PD, Migliaccio AA, Halmagyi GM, Curthoys IS. Vestibulo-ocular reflex pathways in internuclear ophthalmoplegia. Ann Neurol 1999; 45:529.</a></li><li><a class="nounderline abstract_t">Zwergal A, Cnyrim C, Arbusow V, et al. Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus. Neurology 2008; 71:590.</a></li><li><a class="nounderline abstract_t">Sakaie K, Takahashi M, Dimitrov I, et al. Diffusion tensor imaging the medial longitudinal fasciculus in INO: opportunities and challenges. Ann N Y Acad Sci 2011; 1233:307.</a></li><li><a class="nounderline abstract_t">Sakaie K, Takahashi M, Sagiyama K, et al. Injury to a specific neural pathway detected by ultra-high-field MRI. Neurology 2014; 82:182.</a></li><li><a class="nounderline abstract_t">Mills DA, Frohman TC, Davis SL, et al. Break in binocular fusion during head turning in MS patients with INO. Neurology 2008; 71:458.</a></li><li><a class="nounderline abstract_t">Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005; 4:111.</a></li><li><a class="nounderline abstract_t">Zee DS, Hain TC, Carl JR. Abduction nystagmus in internuclear ophthalmoplegia. Ann Neurol 1987; 21:383.</a></li><li><a class="nounderline abstract_t">Baloh RW, Yee RD, Honrubia V. Internuclear ophthalmoplegia. I. Saccades and dissociated nystagmus. Arch Neurol 1978; 35:484.</a></li><li><a class="nounderline abstract_t">Flipse JP, Straathof CS, Van der Steen J, et al. Binocular saccadic eye movements in multiple sclerosis. J Neurol Sci 1997; 148:53.</a></li><li><a class="nounderline abstract_t">Zee DS. Internuclear ophthalmoplegia: pathophysiology and diagnosis. Baillieres Clin Neurol 1992; 1:455.</a></li><li><a class="nounderline abstract_t">Bronstein AM, Rudge P, Gresty MA, et al. Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia. J Neurol Neurosurg Psychiatry 1990; 53:200.</a></li><li><a class="nounderline abstract_t">Keane JR. Internuclear ophthalmoplegia - a reply. Arch Neurol 2006; 63:626.</a></li><li><a class="nounderline abstract_t">Jung DS, Park KP. Posttraumatic bilateral internuclear ophthalmoplegia with exotropia. Arch Neurol 2004; 61:429.</a></li><li><a class="nounderline abstract_t">Eggenberger E. Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy. J Neuroophthalmol 1998; 18:114.</a></li><li><a class="nounderline abstract_t">Kakar P, Brown Z, Banerjee S. Eight-and-a-half syndrome: an unusual presentation of brainstem infarction. QJM 2013; 106:273.</a></li><li><a class="nounderline abstract_t">Marquart C, Strauss C, Alfieri A. Eight-and-a-half syndrome combined with an ipsilateral vertical gaze palsy: a pathophysiological explanation. Clin Neurol Neurosurg 2013; 115:767.</a></li><li><a class="nounderline abstract_t">Sampath Kumar NS, Raju CG, Kiran PR, et al. Eight-and-a-half syndrome: a rare presentation of pontine infarction. J Stroke Cerebrovasc Dis 2014; 23:e389.</a></li><li><a class="nounderline abstract_t">Bocos-Portillo J, Ruiz Ojeda J, Gomez-Beldarrain M, et al. Eight-and-a-Half Syndrome. JAMA Neurol 2015; 72:830.</a></li><li><a class="nounderline abstract_t">Xie WJ, Yu HQ, Wang YH, et al. A case report of eight and a half syndrome. Neurol Sci 2016; 37:821.</a></li><li><a class="nounderline abstract_t">Kong WY, Tan YQ, Sia CH, et al. Adding up cranial nerves to localize the lesion: eight-and-a-half syndrome. QJM 2016; 109:627.</a></li><li><a class="nounderline abstract_t">Bradshaw MJ, Lisak RP, Meltzer E, et al. A young man in "double-trouble": Hallucinations and cranial nerve palsies: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm 2019; 6:e526.</a></li><li><a class="nounderline abstract_t">Nij Bijvank JA, Balk LJ, Tan HS, et al. A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer. J Neurol 2017; 264:600.</a></li><li><a class="nounderline abstract_t">Keane JR. Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients. Arch Neurol 2005; 62:714.</a></li><li><a class="nounderline abstract_t">Müri RM, Meienberg O. The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. Arch Neurol 1985; 42:851.</a></li><li><a class="nounderline abstract_t">Meienberg O, Müri R, Rabineau PA. Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis. Arch Neurol 1986; 43:438.</a></li><li><a class="nounderline abstract_t">Frohman EM, Frohman TC, O'Suilleabhain P, et al. Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score. J Neurol Neurosurg Psychiatry 2002; 73:51.</a></li><li><a class="nounderline abstract_t">Nij Bijvank JA, van Rijn LJ, Balk LJ, et al. Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia. Neurology 2019; 92:e2299.</a></li><li><a class="nounderline abstract_t">Frohman TC, Davis SL, Frohman EM. Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Ann N Y Acad Sci 2011; 1233:313.</a></li><li><a class="nounderline abstract_t">Frohman TC, Davis SL, Beh S, et al. Uhthoff's phenomena in MS--clinical features and pathophysiology. Nat Rev Neurol 2013; 9:535.</a></li><li><a class="nounderline abstract_t">Davis SL, Frohman TC, Crandall CG, et al. Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Neurology 2008; 70:1098.</a></li><li><a class="nounderline abstract_t">Eggenberger E, Golnik K, Lee A, et al. Prognosis of ischemic internuclear ophthalmoplegia. Ophthalmology 2002; 109:1676.</a></li><li><a class="nounderline abstract_t">Gray OM, Forbes RB, Morrow JI. Primary isolated brainstem injury producing internuclear ophthalmoplegia. Br J Neurosurg 2001; 15:432.</a></li><li><a class="nounderline abstract_t">Constantoyannis C, Tzortzidis F, Papadakis N. Internuclear ophthalmoplegia following minor head injury: a case report. Br J Neurosurg 1998; 12:377.</a></li><li><a class="nounderline abstract_t">Matsumoto H, Ohminami S, Goto J, Tsuji S. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. Arch Neurol 2008; 65:827.</a></li><li><a class="nounderline abstract_t">Flint AC, Williams O. Bilateral internuclear ophthalmoplegia in progressive supranuclear palsy with an overriding oculocephalic maneuver. Mov Disord 2005; 20:1069.</a></li><li><a class="nounderline abstract_t">al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994; 89:157.</a></li><li><a class="nounderline abstract_t">Davis TL, Lavin PJ. Pseudo one-and-a-half syndrome with ocular myasthenia. Neurology 1989; 39:1553.</a></li><li><a class="nounderline abstract_t">Korkmaz A, Topaloglu H, Kansu T. Wall eyed bilateral internuclear ophthalmoplegia in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2002; 9:691.</a></li><li><a class="nounderline abstract_t">Lifshitz M, Gavrilov V, Sofer S. Signs and symptoms of carbamazepine overdose in young children. Pediatr Emerg Care 2000; 16:26.</a></li><li><a class="nounderline abstract_t">Solingen LD, Baloh RW, Myers L, Ellison G. Subclinical eye movement disorders in patients with multiple sclerosis. Neurology 1977; 27:614.</a></li><li><a class="nounderline abstract_t">Nij Bijvank JA, Petzold A, Balk LJ, et al. A standardized protocol for quantification of saccadic eye movements: DEMoNS. PLoS One 2018; 13:e0200695.</a></li><li><a class="nounderline abstract_t">Frohman TC, Frohman EM, O'Suilleabhain P, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology 2003; 61:848.</a></li><li><a class="nounderline abstract_t">SMITH JL, DAVID NJ. INTERNUCLEAR OPHTHALMOPLEGIA. TWO NEW CLINICAL SIGNS. Neurology 1964; 14:307.</a></li><li><a class="nounderline abstract_t">Atlas SW, Grossman RI, Savino PJ, et al. Internuclear ophthalmoplegia: MR-anatomic correlation. AJNR Am J Neuroradiol 1987; 8:243.</a></li><li><a class="nounderline abstract_t">Serra A, Skelly MM, Jacobs JB, et al. Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine. Neurology 2014; 83:192.</a></li><li><a class="nounderline abstract_t">Murthy R, Dawson E, Khan S, et al. Botulinum toxin in the management of internuclear ophthalmoplegia. J AAPOS 2007; 11:456.</a></li><li><a class="nounderline abstract_t">Safarpour Y, Mousavi T, Jabbari B. Botulinum Toxin Treatment in Multiple Sclerosis-a Review. Curr Treat Options Neurol 2017; 19:33.</a></li></ol></div><div id="topicVersionRevision">Topic 5239 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11552000" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11552000" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15136670" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/407093" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Bilateral lesions of the medial longitudinal fasciculus in monkeys: effects on the horizontal and vertical components of voluntary and vestibular induced eye movements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3208059" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Vertical vestibulo-ocular reflex, smooth pursuit and eye-head tracking dysfunction in internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15285772" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Internuclear ophthalmoplegia: causes and long-term follow-up in 65 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10211481" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Vestibulo-ocular reflex pathways in internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18711113" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21951009" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Diffusion tensor imaging the medial longitudinal fasciculus in INO: opportunities and challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24285615" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Injury to a specific neural pathway detected by ultra-high-field MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18678831" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Break in binocular fusion during head turning in MS patients with INO.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15664543" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The neuro-ophthalmology of multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3579224" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Abduction nystagmus in internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/666604" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Internuclear ophthalmoplegia. I. Saccades and dissociated nystagmus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9125391" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Binocular saccadic eye movements in multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1344079" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Internuclear ophthalmoplegia: pathophysiology and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2324752" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Internuclear ophthalmoplegia - a reply</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15023822" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Posttraumatic bilateral internuclear ophthalmoplegia with exotropia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9621267" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22011629" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Eight-and-a-half syndrome: an unusual presentation of brainstem infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22835716" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Eight-and-a-half syndrome combined with an ipsilateral vertical gaze palsy: a pathophysiological explanation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24674953" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Eight-and-a-half syndrome: a rare presentation of pontine infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25962103" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Eight-and-a-Half Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26743066" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A case report of eight and a half syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27318368" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Adding up cranial nerves to localize the lesion: eight-and-a-half syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30637300" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A young man in "double-trouble": Hallucinations and cranial nerve palsies: From the National Multiple Sclerosis Society Case Conference Proceedings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28194531" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15883257" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4026628" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3964108" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12082045" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31004067" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21951010" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23732530" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Uhthoff's phenomena in MS--clinical features and pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18287569" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12208716" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prognosis of ischemic internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11708549" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Primary isolated brainstem injury producing internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10070436" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Internuclear ophthalmoplegia following minor head injury: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18541806" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15858806" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Bilateral internuclear ophthalmoplegia in progressive supranuclear palsy with an overriding oculocephalic maneuver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8030396" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2812341" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pseudo one-and-a-half syndrome with ocular myasthenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12453091" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Wall eyed bilateral internuclear ophthalmoplegia in chronic inflammatory demyelinating polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10698139" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Signs and symptoms of carbamazepine overdose in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/559965" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Subclinical eye movement disorders in patients with multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30011322" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A standardized protocol for quantification of saccadic eye movements: DEMoNS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14504338" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14138676" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : INTERNUCLEAR OPHTHALMOPLEGIA. TWO NEW CLINICAL SIGNS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3105283" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Internuclear ophthalmoplegia: MR-anatomic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24907233" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17498988" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Botulinum toxin in the management of internuclear ophthalmoplegia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28819801" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Botulinum Toxin Treatment in Multiple Sclerosis-a Review.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
